162 related articles for article (PubMed ID: 37806994)
1. Diagnostic Utility of Galactomannan Enzyme Immunoassay in Invasive Aspergillosis in Pediatric patients with Hematological Malignancy.
Das S; Capoor MR; Singh A; Agarwal Y
Mycopathologia; 2023 Dec; 188(6):1055-1063. PubMed ID: 37806994
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
[TBL] [Abstract][Full Text] [Related]
3. The role of galactomannan test results in the diagnosis of pediatric invasive aspergillosis.
Özen S; Özdemir H; Evren E; Taşkın EÇ; Arga G; Konca HK; Çakmaklı HF; Haskoloğlu Ş; Okulu E; Dinçaslan H; İnce E; İleri T; Taçyıldız N; Doğu F; Us E; Karahan ZC; Fitöz S; Kendirli T; Kuloğlu Z; Tutar E; İkincioğulları A; Ünal E; Ertem M; İnce E; Çiftçi E
Infect Dis (Lond); 2022 Apr; 54(4):269-276. PubMed ID: 34842498
[TBL] [Abstract][Full Text] [Related]
4. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
[TBL] [Abstract][Full Text] [Related]
5. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
[TBL] [Abstract][Full Text] [Related]
6. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum galactomannan enzyme immunoassay at two different cut-offs for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.
Mohindra R; Capoor MR; Puri S; Raheja H; Gupta DK; Gupta B; Chowdhury R
Indian J Med Microbiol; 2017; 35(2):237-242. PubMed ID: 28681812
[TBL] [Abstract][Full Text] [Related]
8. Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies.
Jha AK; Bansal D; Chakrabarti A; Shivaprakash MR; Trehan A; Marwaha RK
Mycoses; 2013 Jul; 56(4):442-8. PubMed ID: 23369047
[TBL] [Abstract][Full Text] [Related]
9. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
Serin I; Dogu MH
Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
12. Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
Acet-Öztürk NA; Ömer-Topçu D; Vurat-Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Akalın H; Özkalemkaş F; Ener B; Ali R
J Mycol Med; 2022 Nov; 32(4):101304. PubMed ID: 35738036
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
[TBL] [Abstract][Full Text] [Related]
14. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
15. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
[TBL] [Abstract][Full Text] [Related]
16. Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.
de Heer K; Gerritsen MG; Visser CE; Leeflang MM
Cochrane Database Syst Rev; 2019 May; 5(5):CD012399. PubMed ID: 31107543
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis.
Lai CC; Hsu HL; Lee LN; Hsueh PR
J Microbiol Immunol Infect; 2007 Apr; 40(2):148-53. PubMed ID: 17446963
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
[TBL] [Abstract][Full Text] [Related]
19. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
[TBL] [Abstract][Full Text] [Related]
20. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
Danylo A; Courtemanche C; Pelletier R; Boudreault AA
Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
